Julie Gralow

Julie Gralow

UNVERIFIED PROFILE

Are you Julie Gralow?   Register this Author

Register author
Julie Gralow

Julie Gralow

Publications by authors named "Julie Gralow"

Are you Julie Gralow?   Register this Author

100Publications

3010Reads

28Profile Views

Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.

Clin Breast Cancer 2019 Oct 18;19(5):311-316. Epub 2019 Apr 18.

Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2019.04.004DOI Listing
October 2019

Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study.

Clin Cancer Res 2019 Oct 29;25(20):6089-6097. Epub 2019 Jul 29.

Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0208DOI Listing
October 2019

Evaluating the Effect of a Video Education Curriculum for First Time Breast Cancer Patients: a Prospective RCT Feasibility Study.

J Cancer Educ 2019 Jul 29. Epub 2019 Jul 29.

Department of Medicine, Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-019-01578-3DOI Listing
July 2019

Role of Family Obligation Stress on Ugandan Women's Participation in Preventive Breast Health.

Oncologist 2019 May 2;24(5):624-631. Epub 2018 Aug 2.

Community Health Sciences Division, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0553DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516124PMC
May 2019

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.

N Engl J Med 2019 03;380(13):1226-1234

From the Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange (R.S.M.); the SWOG Statistics and Data Management Center (W.E.B., D.L.L.) and Seattle Cancer Care Alliance and University of Washington Medical Center (J.R.G., H.H.L.) - both in Seattle; Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); London Health Sciences Centre and the National Cancer Institute of Canada Clinical Trials Group, London, ON, Canada (T.A.V.); the Cancer Center of Kansas and Wichita National Cancer Institute Community Oncology Research Program (NCORP), Wichita (S.R.D.); Kaiser Permanente NCORP, Portland, OR (N.R.T.); the University of Michigan, Ann Arbor (D.F.H.); the University of Arizona Cancer Center, Tucson (R.B.L.); and the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1811714DOI Listing
March 2019

Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG.

JCO Clin Cancer Inform 2018 12;2:1-8

Don S. Dizon, Lifespan Cancer Institute, Providence, RI; Mina S. Sedrak, City of Hope National Medical Center, Duarte, CA; Mark A. Lewis and Craig Nichols, Intermountain Medical Center, Murray, UT; Elise Cook and Michael J. Fisch, The University of Texas MD Anderson Cancer Center, Houston, TX; Jennifer R. Klemp, University of Kansas Medical Center, Kansas City, KS; Julie Gralow, University of Washington Medical Center, Seattle, WA; Wendy Lawton, Oregon Health and Science University, Portland, OR; and Jonathan Sommers and AnneMarie Ciccarella, Patient Advocates, SWOG Digital Engagement Committee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00122DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668704PMC
December 2018

Breast Cancer Beliefs as Potential Targets for Breast Cancer Awareness Efforts to Decrease Late-Stage Presentation in Uganda.

J Glob Oncol 2018 09 17;4:1-9. Epub 2017 Jul 17.

John R. Scheel, Benjamin O. Anderson, Julie R. Gralow, Fred Hutchinson Cancer Center and University of Washington; Donald L. Patrick, University of Washington; Beti Thompson, Fred Hutchinson Cancer Research Center, Seattle, WA; Yamile Molina, University of Illinois at Chicago, Chicago, IL; Gertrude Nakigudde, Uganda Women's Cancer Support Organization, Kampala, Uganda; and Constance D. Lehman, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JGO.2016.008748
Publisher Site
http://dx.doi.org/10.1200/JGO.2016.008748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180808PMC
September 2018

ASCO Resource-Stratified Guidelines: Methods and Opportunities.

J Glob Oncol 2018 07;4:1-8

Sana Al-Sukhun, Jordanian Oncology Society, Amman, Jordan; Sarah Temin, Thomas K. Oliver, and Doug Pyle, American Society of Clinical Oncology, Alexandria; Neelima Denduluri, Virginia Cancer Specialists, Arlington, VA; Mariana Chavez-MacGregor, University of Texas MD Anderson Cancer Center, Houston, TX; Manish A. Shah, New York-Presbyterian/Weill Cornell Medical Center, New York, NY; and Julie Gralow, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JGO.18.00113
Publisher Site
http://dx.doi.org/10.1200/JGO.18.00113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223500PMC
July 2018

Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.

Clin Breast Cancer 2018 02 9;18(1):e143-e149. Epub 2017 Oct 9.

Department of Medicine, University of Washington, Seattle, WA; Seattle Cancer Care Alliance, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.10.005DOI Listing
February 2018

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

J Clin Oncol 2018 02 12;36(6):563-571. Epub 2018 Jan 12.

Julie Lemieux, Centre Hospitalier Universitaire de Québec, Quebec City, Quebec; Michael D. Brundage, Cancer Centre of Southeastern Ontario at Kingston General Hospital; Wendy R. Parulekar, Kate Whelan, and Dongsheng Tu, Canadian Cancer Trials Group, Kingston; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, McMaster University and Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada; Paul E. Goss, Massachusetts General Hospital Cancer Center, Boston, MA; James N. Ingle, North Central Cancer Treatment Group, Mayo Clinic, Rochester, NY; Paul Celano; Greater Baltimore Medical Center, Baltimore, MD; Hyman Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Julie Gralow, University of Washington, Seattle, WA; and Kathrin Strasser-Weippl, Wilhelminen Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.75.7500
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.75.7500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815404PMC
February 2018

Resource-stratified implementation of a community-based breast cancer management programme in Peru.

Lancet Oncol 2017 10;18(10):e607-e617

Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Surgery, University of Washington, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30592-2DOI Listing
October 2017

Optimal Use of Adjuvant Bisphosphonates and Breast Cancer.

J Clin Oncol 2017 08 27;35(23):2719-2720. Epub 2017 Jun 27.

Trevor J. Powles, Institute of Cancer Research and Cancer Centre London, London, United Kingdom; Alexander H.G. Paterson, University of Calgary, Calgary, Alberta, Canada; and Julie R. Gralow, University of Washington School of Medicine and Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.6157DOI Listing
August 2017

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

J Clin Oncol 2017 May 13;35(13):1421-1429. Epub 2017 Mar 13.

Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom; Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy; Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles; Debora Fumagalli, Breast International Group, Brussels, Belgium; Severine Sarp, Novartis Pharma AG, Basel, Switzerland; Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD; Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH; Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA; Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL; Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark; Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands; Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia; Sergio D. Simon, Hospital Israelita Albert Einstein; Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil; Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile; Masakazu Toi, Kyoto University, Kyoto, Japan; Maccon Keane, University Hospital Galway, Galway; and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.7722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455460PMC
May 2017

The challenge of measuring intra-individual change in fatigue during cancer treatment.

Qual Life Res 2017 02 28;26(2):259-271. Epub 2016 Jul 28.

Department of Medical Social Sciences and Center for Patient-Centered Outcomes, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-016-1372-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274585PMC
February 2017

Breast Cancer Outlook for 2017: Keeping the Accelerator to the Floor.

Oncology (Williston Park) 2016 12;30(12 Suppl 2):1-2, 15

View Article

Download full-text PDF

Source
December 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N Engl J Med 2016 Jul 5;375(3):209-19. Epub 2016 Jun 5.

From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1604700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024713PMC
July 2016

Hot flashes in breast cancer survivors: Frequency, severity and impact.

Breast 2016 Jun 8;27:116-21. Epub 2016 Apr 8.

Division of Medical Oncology, University of Washington School of Medicine, 825 Eastlake Ave E., Seattle, WA, 98109-1023, United States; Breast Medical Oncology, Seattle Cancer Care Alliance, 825 Eastlake Ave East, G3-630, Seattle, WA, 98109, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2016.02.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893329PMC
June 2016

Screening MRI in Women With a Personal History of Breast Cancer.

J Natl Cancer Inst 2016 Mar 7;108(3). Epub 2016 Jan 7.

Department of Radiology, Massachusetts General Hospital, Boston, MA (CDL); Department of Radiology, University of Washington Medical Center, Seattle, WA (JML, DSH, GK, SCP); Seattle Cancer Care Alliance, Seattle, WA (JML, SCP); Department of Radiology, University of Wisconsin-Madison, Madison, WI (WBD); Department of Pathology, University of Washington Medical Center, Seattle, WA (MHR); Fred Hutchinson Cancer Research Center, Seattle, WA, (PP, JG); Department of Medical Oncology, University of Washington Medical Center, Seattle, WA (JG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv349DOI Listing
March 2016

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

J Clin Oncol 2016 Mar 11;34(7):699-705. Epub 2016 Jan 11.

Stuart M. Lichtman and Maria Theodoulou, Memorial Sloan Kettering Cancer Center, New York, NY; Constance T. Cirrincione, Duke University; Harvey Jay Cohen, Duke University Medical Center, Durham; Gustave Magrinat, Cone Health Cancer Center, Greensboro; Hyman B. Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte, CA; Aminah Jatoi, Mayo Clinic, Rochester, MN; Antonio C. Wolff, The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD; Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA; and Daniel E. Morganstern, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.6341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872024PMC
March 2016

Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.

BMC Cancer 2015 Jul 22;15:535. Epub 2015 Jul 22.

Division of Oncology, Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, WA, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1536-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510889PMC
July 2015

Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.

J Clin Oncol 2015 Jun 4;33(17):1910-7. Epub 2015 May 4.

Dawn L. Hershman, Katherine D. Crew, Danielle Awad, and Heather Greenlee, Columbia University Medical Center, New York, NY; Joseph M. Unger, Danika L. Lew, and Cathee Till, Southwest Oncology Group Statistical Center; Joseph M. Unger, Julie Gralow, Danika L. Lew, Cathee Till, and Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Lori M. Minasian, National Cancer Institute, Bethesda, MD; James L. Wade III, Central Illinois Community Clinical Oncology Program/Cancer Care Specialists of Central Illinois, Decatur, IL; and Frank L. Meyskens, University of California at Irvine, Chao Family Comprehensive Cancer Center, Orange, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.59.5595
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.5595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451174PMC
June 2015

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

J Clin Oncol 2015 Mar 20;33(7):701-8. Epub 2015 Jan 20.

Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334774PMC
March 2015

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

N Engl J Med 2015 Mar;372(10):923-32

From the Cleveland Clinic Foundation, Cleveland (H.C.F.M.); SWOG Cancer Research Group Statistical Center, Fred Hutchinson Cancer Research Center (J.M.U., W.E.B.), and Seattle Cancer Care Alliance and University of Washington (J.G.) - all in Seattle; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC (K.-A.P., P.A.F.), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) (K.-A.P., P.A.F., J.F.F.), Calvary Mater Hospital, Newcastle, NSW (F.B., J.M.L., J.F.F.), and University of Sydney, Sydney (F.B.) - all in Australia; International Breast Cancer Study Group (IBCSG), Bern, Switzerland (K.-A.P., P.A.F.); National Institute of Oncology, Budapest, Hungary (E.H.); Auckland Regional Cancer and Blood Service, Auckland, New Zealand (D.P.); Fox Chase Cancer Center, Philadelphia (L.J.G.); Instituto de Enfermedades Neoplasicas (H.L.G.) and Oncosalud SAC (C.S.V.), Lima, Peru; Dana-Farber Cancer Institute (A.H.P., R.D.G.) and IBCSG Statistical Center (R.D.G.) - both in Boston; Wichita Community Clinical Oncology Program, Wichita (S.R.D.), and University of Kansas, Westwood (C.J.F.) - both in Kansas; University of Southern California Norris Cancer Center, Los Angeles (A.A.G.), the Angeles Clinic and Research Institute, Santa Monica (S.M.), and University of California at Irvine Chao Family Comprehensive Cancer Center, Orange (F.L.M) - all in California; National Cancer Institute, Division of Cancer Prevention, Bethesda, MD (L.M.); M.D. Anderson Cancer Center, Houston (G.N.H.); and Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL (K.S.A.).

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/obgynsurvey/2015/06000/Gosereli
Web Search
http://www.nejm.org/doi/abs/10.1056/NEJMoa1413204
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1413204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405231PMC
March 2015

Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.

Pharmacoepidemiol Drug Saf 2015 Jan 13;24(1):75-85. Epub 2014 Jun 13.

Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.3660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265308PMC
January 2015

Tumor marker usage and medical care costs among older early-stage breast cancer survivors.

J Clin Oncol 2015 Jan 20;33(2):149-55. Epub 2014 Oct 20.

Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279234PMC
January 2015

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.

J Clin Oncol 2015 Jan 24;33(1):58-64. Epub 2014 Nov 24.

George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.3296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268253PMC
January 2015

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

J Clin Oncol 2014 Nov 2;32(31):3483-9. Epub 2014 Jun 2.

Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/06/02/JCO.2014.56
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.2561
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.2561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209100PMC
November 2014

Metabolic syndrome and outcomes following early-stage breast cancer.

Breast Cancer Res Treat 2014 Nov 10;148(2):363-77. Epub 2014 Oct 10.

Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, 833 S. Wood St. M/C 871, Room 287, Chicago, IL, 60612, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-014-3157
Web Search
http://link.springer.com/10.1007/s10549-014-3157-6
Publisher Site
http://dx.doi.org/10.1007/s10549-014-3157-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236717PMC
November 2014

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

J Clin Oncol 2014 Nov 20;32(33):3744-52. Epub 2014 Oct 20.

Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226805PMC
November 2014

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2014 Oct 2;32(29):3307-29. Epub 2014 Sep 2.

Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical Oncology Unit, Prato, Italy; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Douglas Yee, University of Minnesota/Masonic Cancer Center, Minneapolis, MN; Shelley B. Brundage, Patient Representative, Washington, DC; Maggie Wilcox, Independent Cancer Patients' Voice; and Ian E. Smith, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.56.7479
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.7479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076042PMC
October 2014

Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial.

J Clin Oncol 2014 Jul 16;32(21):2231-9. Epub 2014 Jun 16.

Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario; Michael Vallis, Dalhousie University, Halifax, Nova Scotia; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Jennifer A. Ligibel, Dana-Farber Cancer Institute; George L. Blackburn, Beth Israel Deaconess Medical Center; Jennifer A. Ligibel and George L. Blackburn, Harvard Medical School, Boston, MA; and Julie R. Gralow, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1517DOI Listing
July 2014

Promoting quality and evidence-based care in early-stage breast cancer follow-up.

J Natl Cancer Inst 2014 Apr 13;106(4):dju034. Epub 2014 Mar 13.

Affiliations of authors: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI (NLH, DFH); Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA (SDR, JRG); Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (GNH); Department of Biostatistics, University of Washington, Seattle, WA (WEB).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/106/4/dju034.full.pdf
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju034
Publisher Site
http://dx.doi.org/10.1093/jnci/dju034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311189PMC
April 2014

Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer.

Gen Hosp Psychiatry 2013 Jul-Aug;35(4):376-81. Epub 2013 May 1.

University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.genhosppsych.2013.03.017DOI Listing
February 2014

Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.

Breast Cancer Res Treat 2014 Feb 10;143(3):541-50. Epub 2014 Jan 10.

Department of Pharmacy, University of Washington, 1959 NE Pacific St, Box 357630, Seattle, WA, 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2816-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935518PMC
February 2014

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.

Breast Cancer Res Treat 2014 Jan 19;143(2):351-8. Epub 2013 Dec 19.

University of Washington School of Medicine/Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-630, Seattle, WA, 98109, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2797-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889983PMC
January 2014

Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.

Clin Cancer Res 2013 Oct 21;19(20):5798-807. Epub 2013 Aug 21.

Authors' Affiliations: Section of Biostatistics; Division of Anatomic Pathology, Mayo Clinic, Scottsdale, Arizona; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology; Division of Biomedical Statistics and Informatics and Medical Oncology, Mayo Clinic, Rochester, Minnesota; Division of Anatomic Pathology and Hematology/Oncology, Mayo Clinic, Jacksonville, Florida; Division of Hematology/Oncology, University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, Pennsylvania; The Angeles Clinic and Research Institute, Santa Monica, California; Indiana University Medical Center Cancer Pavilion, Indianapolis, Indiana; Division of Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Oncology Associates of Cedar Rapids, Cedar Rapids, Iowa; Seattle Cancer Care Alliance, Seattle, Washington; and Case Western Reserve University, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805021PMC
October 2013

Frequent antibiotic use and second breast cancer events.

Cancer Epidemiol Biomarkers Prev 2013 Sep 5;22(9):1588-99. Epub 2013 Jul 5.

Departments of Pharmacy, Biostatistics, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769442PMC
September 2013

The importance of survivors and partners in improving breast cancer outcomes in Uganda.

Breast 2013 Apr 10;22(2):138-141. Epub 2013 Jan 10.

University of Washington, Department of Medical Oncology, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2012.12.017DOI Listing
April 2013

Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.

Breast Cancer Res Treat 2012 Dec 27;136(3):777-88. Epub 2012 Oct 27.

Baylor-Charles A. Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Suite 400, Dallas, TX 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2288-xDOI Listing
December 2012

Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries.

Int J Gynaecol Obstet 2012 Oct 9;119 Suppl 1:S85-8. Epub 2012 Aug 9.

Harvard Global Equity Initiative, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijgo.2012.03.024DOI Listing
October 2012

Can bone-targeted therapy reduce recurrence and improve survival in early-stage breast cancer?

Authors:
Julie Gralow

Oncology (Williston Park) 2012 Oct;26(10):969-70

University of Washington School of Medicine, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
October 2012

Hypnosis for symptom management in women with breast cancer: a pilot study.

Int J Clin Exp Hypn 2012 ;60(2):135-59

University of Washington School of Medicine, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00207144.2012.648057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865596PMC
July 2012

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.

Oncologist 2012 20;17(2):179-87. Epub 2012 Jan 20.

University of Michigan, Division of Hematology/Oncology, 24 Frank Lloyd Wright Drive, Suite A3400, PO Box 483, Ann Arbor, Michigan 48106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286166PMC
June 2012

Current treatment options in triple negative breast cancer.

Breast Dis 2010 ;32(1-2):99-122

University of Washington, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BD-2010-0304DOI Listing
February 2012

How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?

J Clin Oncol 2011 Sep 15;29(26):3591-2; author reply 3592-3. Epub 2011 Aug 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.5759DOI Listing
September 2011

Can we predict who's at risk for developing bone metastases in breast cancer?

J Clin Oncol 2011 Sep 22;29(27):3600-4. Epub 2011 Aug 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.7038DOI Listing
September 2011

Axillary vs sentinel lymph node dissection for invasive breast cancer.

JAMA 2011 Jun;305(22):2290; author reply 2290-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2011.754DOI Listing
June 2011

Bisphosphonate risks and benefits: finding a balance.

Authors:
Julie R Gralow

J Clin Oncol 2010 Nov 12;28(33):4873-6. Epub 2010 Oct 12.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.31.1464
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.31.1464DOI Listing
November 2010